Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2
What this study shows
Insulin activates Rheb-GTP, inhibited by TSC1/2, positioning Rheb as the direct upstream activator of TOR.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Drosophila & mammalian cells) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Drosophila & mammalian cells |
| Journal | Molecular cell |
| Year | 2003 |
| Peer reviewed | Yes |
| Record last updated | 2026-08-22 |
| Source | DOI 10.1016/s1097-2765(03)00220-x · PMID 12820960 |
Extracted findings
| Intervention | Genetic/biochemical (Rheb, TSC1/2) |
| Target | Rheb / TSC1-TSC2 / mTOR-S6K-4EBP |
| Model | Drosophila & mammalian cells |
| Effect | Insulin activates Rheb, a mediator of mTOR/S6K/4E-BP signaling, and this is inhibited by TSC1/2 |
In the Atlas
Related topics
More studies on this topic
- Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling (2003)
- Rheb binds and regulates the mTOR kinase (2005)
- PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase (2007)
- Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids (2010)
Learn the biology
Want to understand the biology behind this study? → Rheb — The Critical Regulator